FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?

ESMO Open. 2020 Oct;5(5):e000633. doi: 10.1136/esmoopen-2019-000633.

¹ Department of Medical Oncology, The Christie NHS Foundation Trust; Division of Cancer Sciences, University of Manchester, Manchester, UK.
² Department of Pathology, Manchester Royal Infirmary, Manchester, UK.
³ Division of Cancer Sciences, University of Manchester; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. Electronic address: juan.valle@christie.nhs.uk.
⁴ Department ogf HPB Surgery, Manchester Royal Infirmary, Manchester, UK.

No abstract available

Keywords: FOLFIRINOX; FOLFOXIRIx; chemotherapy; duodenal cancer; small bowel.

Publication types